Access cutting-edge chronic lymphocytic leukemia treatment through this clinical trial at a research site in Canton. Study-provided care at no cost to qualified participants.
Access chronic lymphocytic leukemia specialists in Canton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic lymphocytic leukemia treatment provided free
The primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period will reduce the rate of major bacterial infections per participant per year in B-cell CLL, MM, and NHL participants with hypogammaglobulinemia (HGG) in comparison to the Placebo plus SMT group.
Sponsor: Grifols Therapeutics LLC
Check if you qualify for this chronic lymphocytic leukemia clinical trial in Canton, OH
If you're searching for chronic lymphocytic leukemia treatment options in Canton, OH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Canton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic lymphocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.